| 1 |
–5.548 |
25.16 |
–5.29 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 3.00 |
| |
|
|
|
N 11 OD2 ASP 300 H-donor
3.24 |
| 2 |
–5.777 |
–27.14 |
–5.66 |
ligand–receptor
interaction distance |
| |
|
|
|
N 11 OD2 ASP 300 H-donor 2.94 |
| 3 |
–5.466 |
–26.78 |
–5.30 |
ligand–receptor@@
interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 3.05 |
| |
|
|
|
6-ring 5-ring TRP 59 pi-pi 3.58 |
| |
|
|
|
6-ring 6-ring
TRP 59 pi-pi 3.99 |
| 4 |
–5.767 |
–27.90 |
–5.61 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 2.97 |
| |
|
|
|
N 11 OD2 ASP 300 H-donor
3.26 |
| 5 |
–5.814 |
–28.06 |
–5.62 |
ligand–receptor
interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 3.05 |
| |
|
|
|
N 11 OD2 ASP 300 H-donor 3.00 |
| 6 |
–5.165 |
–29.75 |
–5.81 |
ligand–receptor interaction
distance |
| |
|
|
|
N 11 OD1 ASP 197 (A) H-donor 3.02 |
| |
|
|
|
5-ring CB ALA 198 (A) pi-H 4.67 |
| 7 |
–5.468 |
–30.35 |
–6.15 |
ligand–receptor interaction distance |
| |
|
|
|
5-ring CB TYR 62 pi-H 4.04 |
| 8 |
–5.6 |
–34.41 |
–5.98 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OE1 GLU 233 H-donor 2.4 |
| |
|
|
|
6-ring CB TRP
59 pi-H 3.3 |
| |
|
|
|
6-ring CD1 LEU 162 pi-H 3.6 |
| 9 |
–5.685 |
–26.76 |
–5.41 |
ligand–receptor
interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 (A) H-donor
3.10 |
| |
|
|
|
N 11 OD2 ASP 300 (A) H-donor 2.94 |
| 10 |
–5.296 |
–35.44 |
–6.28 |
ligand–receptor
interaction distance |
| |
|
|
|
N 20 OD1 ASP 300 H-donor 3.18 |
| |
|
|
|
5-ring CB TRP 59 pi-H 3.87 |
| 11 |
–6.48 |
–33.37 |
–6.32 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 3.04 |
| |
|
|
|
N 11 OD2 ASP 300
H-donor 3.11 |
| |
|
|
|
C 13 6-ring TYR 62 H-pi 4.22 |
| 12 |
–6.756 |
–38.25 |
–6.92 |
ligand–receptor
interaction distance |
| 12 |
|
|
|
N 11 OE2 GLU 240
H-donor 3.08 |
| 13 |
–5.135 |
–29.03 |
–5.80 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OD1 ASP 197 H-donor 2.91 |
| |
|
|
|
BR 33 OD2 ASP 356 H-donor
3.2 |
| 14 |
–5.212 |
–28.85 |
–5.99 |
ligand–receptor
interaction distance |
| |
|
|
|
O 22 CE1 HIS 201 H-acceptor 3.23 |
| 15 |
–5.625 |
–27.84 |
–5.61 |
ligand–receptor
interaction distance N 11 OD2 ASP 300
H-donor 1.74 |
| |
|
|
|
6-ring CD2 LEU 165 pi-H 2.8 |
| |
|
|
|
5-ring CB ALA 198 pi-H 3.13 |
| |
|
|
|
6-ring CE1 HIS 201 pi-H
3.95 |
| 16 |
–5.444 |
–27.69 |
–5.73 |
ligand–receptor
interaction distance |
| |
|
|
|
N 11 OD1 ASP 197 H-donor 2.99 |
| |
|
|
|
6-ring CD1 LEU 162 pi-H 4.79 |
| 17 |
–5.35 |
–25.44 |
–5.06 |
ligand–receptor interaction
distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 3.08 |
| 18 |
–5.066 |
–31.00 |
–5.78 |
ligand–receptor interaction
distance |
| |
|
|
|
N 20 OD1 ASP 300 H-donor 3.09 |
| 19 |
–5.331 |
–28.92 |
–5.81 |
ligand–receptor interaction
distance |
| |
|
|
|
I 33 OD2 ASP 356 H-donor 3.91 |
| |
|
|
|
5-ring CB ALA 198 pi-H 4.70 |
| 20 |
–5.221 |
–31.46 |
–5.89 |
ligand–receptor interaction distance |
| |
|
|
|
N 20 OD1 ASP 300 H-donor 2.89 |
| 21 |
–5.6 |
–32.31 |
–5.99 |
ligand–receptor interaction
distance |
| |
|
|
|
N 20 OD1 ASP 300 H-donor 1.75 |
| |
|
|
|
O 22 NH2 ARG 195 H-acceptor 1.89 |
| |
|
|
|
O 22 NE2 HIS 299
H-acceptor 2.00 |
| 22 |
–5.807 |
–32.81 |
–6.40 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OD1 ASP 300 H-donor 3.02 |
| |
|
|
|
6-ring 5-ring TRP 59
pi-pi 3.71 |
| 23 |
–5.683 |
–26.56 |
–5.48 |
ligand–receptor interaction distance |
| |
|
|
|
N 11 OD2 ASP 300 H-donor 3.07 |
| |
|
|
|
C 13 6-ring TYR 62 H-pi
4.15 |
| 24 |
–5.658 |
–32.99 |
–5.75 |
ligand–receptor
interaction distance |
| |
|
|
|
N 11 OE1 GLU 233 H-donor 2.5 |
| |
|
|
|
6-ring CB TRP 59 pi-H 3.4 |
| |
|
|
|
6-ring CD1 LEU
162 pi-H 3.6 |